Search
for
Sort by
Research 25
- Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Tyrosine kinase inhibition and grey hair
- Imatinib-induced classical lichen planopilaris in blaschko-linear distribution leading to cicatricial alopecia
- Author reply
- Skin manifestations of chronic kidney disease
- Effets secondaires cutanéo-muqueux des nouvelles molécules anticancéreuses: Inhibiteurs de l'EGF-R, inhibiteurs de tyrosine kinase et stabilisateurs du fuseau mitotique
- Hair Depigmentation Is a Biological Readout for Pharmacological Inhibition of KIT in Mice and Humans
- The PDGF/PDGFR pathway as a drug target
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Drug eruptions in dermatology
- Cutaneous drug reactions
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy
- Medications
- Cutaneous Drug Reaction Case Reports
- Index
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Protein Kinase C as a Therapeutic Target
- PROTACs: A novel strategy for cancer drug discovery and development
- Anticancer agents against malaria: time to revisit?
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Effective holistic characterization of small molecule effects using heterogeneous biological networks
- Reductive Stress Selectively Disrupts Collagen Homeostasis and Modifies Growth Factor-independent Signaling Through the MAPK/Akt Pathway in Human Dermal Fibroblasts
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies